18:37 , Apr 4, 2019 |  BC Extra  |  Company News

Management tracks: Gottlieb's next move, plus Vertex, Centogene and more

FDA Commissioner Scott Gottlieb will return to the American Enterprise Institute as a resident fellow after he leaves the agency. His last day at FDA is Friday. Gottlieb expects to work part-time at AEI, where...
16:59 , Feb 22, 2019 |  BC Week In Review  |  Clinical News

FDA clears Bio-Rad's PCR system as first digital PCR products

Bio-Rad Laboratories Inc. (NYSE:BIO) said its digital PCR system is the first to receive FDA clearance. FDA cleared the QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS...
00:50 , Jan 5, 2019 |  BC Extra  |  Company News

Flurry of management moves on eve of JPM

More than 30 biopharma companies announced executive changes to kick off the New Year, including Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and Immunocore Ltd. (Abingdon, U.K.), both of which brought on former AstraZeneca plc (LSE:AZN; NYSE:AZN) executives...
03:31 , Dec 7, 2018 |  BC Innovations  |  Tools & Techniques

Germline editing gets technical

As the smoke clears from Jiankui He’s bombshell germline editing announcement, the gap between where the gene editing field is now and where it would need to be to support responsible germline editing has become...
22:53 , Nov 3, 2017 |  BC Extra  |  Company News

Management tracks: Tissue Regenix, Therapix

Regenerative medical device company Tissue Regenix Group plc (LSE:TRX) named Steve Couldwell CEO. A Tissue Regenix director since 2013, Couldwell was COO of global biosurgery at Sanofi (Euronext:SAN; NYSE:SNY). Cannabinoid company Therapix Biosciences Ltd. (Tel...
23:47 , Jul 5, 2017 |  BC Extra  |  Company News

Management tracks

Regenacy Pharmaceuticals LLC (Boston, Mass.) named Simon Jones president and CEO. He was VP of biology at EPIX Pharmaceuticals Inc. (Pink:EPIX). Jones succeeds Walter Ogier, who will remain a director. Last December, Acetylon Pharmaceuticals Inc....
00:17 , Apr 29, 2017 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 19 biotechs and pharmas are expected to report earnings this week. (A) Fiscal 2Q; (B) Fiscal 3Q Company Date Pre/post mkt 1Q17 EPS est 1Q16 EPS Expected chg Luminex Corp....
23:51 , Feb 17, 2017 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least nine biotechs and pharmas are expected to report earnings this week. (A) Reported and estimated EPS for 12 months Company Date Pre/post mkt 4Q16 EPS est 4Q15 EPS Expected chg...
04:37 , Jan 27, 2017 |  BC Week In Review  |  Company News

Illumina, Bio-Rad deal

Illumina launched a single-cell sequencing platform in collaboration with Bio-Rad. The Illumina Bio-Rad Single-Cell Sequencing Solution is designed to allow next-generation sequencing of single cells and includes data analysis from Illumina's cloud-based genomic computing environment....
00:00 , Jan 11, 2017 |  BC Extra  |  Company News

Illumina rises after introducing new products, deals

Illumina Inc. (NASDAQ:ILMN) gained $23.50 (17%) to $165.04 on Tuesday after introducing new products and collaborations, including the launch of the NovaSeq series of high throughput sequencers. The company said the systems could "one day"...